Navigation Links
Trans-Atlantic agreement a boost to neuroscience research
Date:5/10/2010

This release is available in French.

Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field. Sir Keith O'Nions, Rector of Imperial, and Heather Munroe-Bloom, Principal and Vice-Chancellor of McGill, met in London to sign the partnership documents, which will consolidate existing scientific collaborations and provide new support for creating a framework for regular academic interactions.

"McGill and Imperial share common interests and strengths in such important fields of transformational research as brain imaging, motor neuron diseases, movement disorders and neuroimmunology," Munroe-Blum said. "I am delighted that the long-standing collaboration between these two leading institutions has been broadened, offering us the opportunity to strengthen and expand our research programs and eventually achieve major advances in our understanding of human neurological disorders."

"The neurosciences are an extremely important and interdisciplinary field of research focused on some of the major health challenges we face today," said Sir Keith. "We are making great strides in understanding how the brain works physically and biochemically, and this work is key to improving mental health. We at Imperial are delighted to have as our partner a leading institution that shares our appetite to carry out excellent research and move it quickly out of the lab to create new therapies for the people who need it."

Neurosciences research is one of McGill's top institutional priorities, building on the distinguished history and current strengths of its Montreal Neurological Institute (MNI) and the Douglas Mental Health University Institute. McGill's integrated program in neurosciences is one of the largest contemporary neuroscience graduate programs in North America. At Imperial, neurosciences research focuses particularly on mechanisms of brain degeneration and restoration of function, systems neuroscience, brain development, pain, anaesthesia, muscular dystrophy, neuroinflammatory disorders such as multiple sclerosis, addiction, molecular neuroimaging, cognitive neuroscience, neurogenetics and various aspects of mental health. Research achievements at the College include the first demonstration that variant CJD is caused by the same prion as BSE.


'/>"/>

Contact: William Raillant-Clark
william.raillant-clark@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert  

Related medicine news :

1. EPA and NASA administrators to extend environmental and Earth science agreement
2. More common ground in health care reform law disagreement than meets the eye
3. BCS Global and Iformata Sign Agreement to Collaborate on the PSVN Initiative to Deliver B2B Video Communications
4. Online Tech and VersaIMAGE Sign SaaS Hosting Agreement
5. VisionQwest Global Group Signs Distribution Agreement with Creative Trade World, Inc.
6. Oridion and Masimo Sign Distribution Agreement to Sell Capnostream™20 Bedside Monitors with the Masimo Patient SafetyNet™ System
7. Online Tech and Healthmaster Sign SaaS Hosting Agreement
8. Stellaris Health Network Hospitals Reach New Agreement with CIGNA HealthCare
9. Sigma-Aldrich Reaches Agreement to Sell Pfizers Bioactive Small Molecule Compounds
10. Historic Agreement Reached to Transition Illinois Residents Unnecessarily Housed in Large, Impersonal Nursing Homes
11. Brain Science Institute announces license agreement to develop treatments for neurological disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Trans-Atlantic agreement a boost to neuroscience research
(Date:4/24/2017)... Tx (PRWEB) , ... April 24, 2017 , ... ... Lief Therapeutics designed to recognize elevated anxiety levels in people with addiction who ... the Lief Smart Patch, a biosensing wearable device that monitors heart and breath ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on ... Blvd, for an educational and exciting 2-day program. , An attendee at a ... before they approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain ...
(Date:4/24/2017)... ... ... “Reflections of God’s Work”: an enlightening collection of life lessons leading each ... published author, Jerri Broglin, a survivor of great loss who gained insight on how ... for those searching for answers, as we are finding the answers that are so ...
(Date:4/24/2017)... Gainesville, Florida (PRWEB) , ... April 24, 2017 , ... ... at the University of Florida. The event will be held at 7:30 pm on ... and Ken Block and Drew Copeland of Sister Hazel, will support the UF Collegiate ...
(Date:4/23/2017)... ... 23, 2017 , ... "An event Horizon is a place where the laws ... Art and Music. These are created as Metaphysical Transformations where music, which is the ... to the ultimate singularity.", -- Karen Salicath Jamali , Karen will also preview her ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... , April 21, 2017 Halo Labs ... throughput biopharmaceutical particle analysis system called the Horizon at ... May 1st. The new system analyzes sub visible particulate ... time rapid particle screening as early as candidate selection ... with leading biopharma contract research organization Elion Labs ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
Breaking Medicine Technology: